A recent study has identified a genetic link between the use of GLP-1 weight-loss medications and an increased risk of hair loss in men.
While these drugs are effective for managing Type 2 diabetes and obesity, researchers found that patients with a genetic predisposition to baldness are more susceptible to this side effect.
Medical professionals are now advising patients to monitor hair health during treatment and discuss potential preventative measures with their healthcare providers.